Home » CELERA, MEDAREX COLLABORATE ON THERAPEUTIC ANTIBODY
CELERA, MEDAREX COLLABORATE ON THERAPEUTIC ANTIBODY
Celera Genomics, an Applera Corporation business, and Medarex Inc. have entered into a collaboration to discover and develop human antibodies for the potential treatment of multiple cancer indications.
Biospectrum Asia (http://www.biospectrumasia.com/content/260606OTH1000.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May